Managing the Silent Epidemic of Nonalcoholic Fatty Liver Disease.
作者信息
Fuchs Michael
机构信息
is Chief of Hepatology and Liver Transplantation at Hunter Holmes McGuire VAMC in Richmond, Virginia. He also is a Professor of Medicine at Virginia Commonwealth University in Richmond.
出版信息
Fed Pract. 2019 Jan;36(1):12-13.
Abstract
摘要
相似文献
1
Managing the Silent Epidemic of Nonalcoholic Fatty Liver Disease.应对非酒精性脂肪性肝病这一无声的流行病。
Fed Pract. 2019 Jan;36(1):12-13.
2
Nonalcoholic Fatty Liver Disease: A Silent Epidemic.非酒精性脂肪性肝病：一种隐匿的流行病。
Gastroenterol Nurs. 2019 Sep/Oct;42(5):428-434. doi: 10.1097/SGA.0000000000000443.
3
Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的诊断与治疗意义
Gastroenterol Hepatol (N Y). 2019 Feb;15(2):83-89.
4
The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病之谜：从非酒精性脂肪肝到非酒精性脂肪性肝炎的进展
J Clin Exp Hepatol. 2015 Jun;5(2):147-58. doi: 10.1016/j.jceh.2015.02.002. Epub 2015 Feb 16.
5
The future liver of the Asia pacific: fatter and firmer from more fructose and fortune?亚太地区未来的肝脏：因更多果糖和财富而更胖更硬？
J Clin Exp Hepatol. 2013 Jun;3(2):106-13. doi: 10.1016/j.jceh.2012.10.011. Epub 2012 Dec 28.
6
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.非酒精性脂肪性肝病和非酒精性脂肪性肝炎在美国和世界其他地区的流行病学。
Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.
7
Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.非酒精性脂肪性肝病的严重程度：东方视角
J Clin Exp Hepatol. 2019 Jul-Aug;9(4):491-496. doi: 10.1016/j.jceh.2019.01.007. Epub 2019 Feb 7.
8
Nonalcoholic fatty liver disease remission in men through regular exercise.男性通过规律运动实现非酒精性脂肪性肝病缓解
J Clin Biochem Nutr. 2018 May;62(3):242-246. doi: 10.3164/jcbn.17-115. Epub 2018 Mar 17.
9
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.非酒精性脂肪性肝病与心血管疾病表型
SAGE Open Med. 2020 Jun 20;8:2050312120933804. doi: 10.1177/2050312120933804. eCollection 2020.
10
Fatty liver and the metabolic syndrome.脂肪肝与代谢综合征
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9.
引用本文的文献
1
Improved pathology reporting in NAFLD/NASH for clinical trials.改善用于临床试验的非酒精性脂肪性肝病/非酒精性脂肪性肝炎的病理报告。
J Clin Pathol. 2022 Feb;75(2):73-75. doi: 10.1136/jclinpath-2021-207967. Epub 2021 Nov 9.
2
Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).诊断为非酒精性脂肪性肝病（NAFLD）或非酒精性脂肪性肝炎（NASH）的患者的所需华法林剂量和治疗范围内的时间。
PLoS One. 2021 Sep 15;16(9):e0251665. doi: 10.1371/journal.pone.0251665. eCollection 2021.
Zotero 插件